Can P16INK4A expression reliably distinguish harmful from beneficial senescent microglia in neurodegeneration?

PARTIALLY ADDRESSED

The debate proposed P16INK4A-guided targeting but the Skeptic noted microglia exist in complex activation states that don't fit binary classifications. This fundamental question determines whether selective senolytic approaches are viable versus broad clearance strategies. Source: Debate session sess_SDA-2026-04-02-gap-senescent-clearance-neuro (Analysis: SDA-2026-04-02-gap-senescent-clearance-neuro)

Priority: 0.90 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Can P16INK4A expression reliably distinguish harmful from beneficial senescent microglia in neurodegeneration? is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Can P16INK4A expression reliably distinguish harmful from beneficial senescent microglia in neurodegeneration? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (10)

P16INK4ACancerP16INK4AAtaxiaCDKN2AP16INK4ATP53P16INK4AP53P16INK4A
▸ Show 5 more

biomarker for (11)

P16INK4ASenescenceP16INK4AApoptosisBCL2L1P16INK4AP16INK4AAPOPTOSISP21CIP1P16INK4A
▸ Show 6 more

expressed in (1)

P16INK4AT Cell

regulates (23)

P16INK4AAgingP16INK4AAlsP16INK4AObesityP16INK4AInflammationP16INK4ADiabetes
▸ Show 18 more
🕑 Activity Feed
update on knowledge_gap by max_gmail 2026-04-28T00:18
update on knowledge_gap by None 2026-04-25T22:15
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps